Key Takeaways Lilly stock moved above its 50-day SMA after a rebound from post-Q2 declines.ATTAIN-2 study success for oral obesity drug eased earlier investor concerns.Mounjaro and Zepbound now drive about half of Lilly's revenues on rising demand.Eli Lilly and Company’s (LLY) stock moved past the 50-day Simple Moving Average (SMA) last week after trading below the same since the end of July. When a stock's price moves above its 50-day SMA, it signals a potential bullish trend. Image Source: Zacks Investmen ...